Navigation Links
Senator Dianne Feinstein Denounces Prop 8
Date:10/28/2008

Feinstein Speaks Directly to Voters in New Television Ad

SACRAMENTO, Calif., Oct. 28 /PRNewswire/ -- Today the NO on Prop 8 campaign released a new television spot featuring Senator Diane Feinstein who, speaking directly to voters, tells Californians "Proposition 8 would be a terrible mistake for California. It's about discrimination and we must always say NO to that."

"We are so moved to have the strong, trusted and independent voice of Senator Feinstein joining the chorus of those voting NO on 8," said Patrick Guerriero, Campaign Director for NO on Prop 8 . "California voters know that Senator Feinstein speaks from the heart and it matters when she urges voters to reject this unfair initiative."

The Feinstein ad represents a significant purchase by the NO on Prop 8 campaign and will run statewide.

Feinstein, speaking directly to the camera, says:

"In my lifetime, I've seen discrimination. And I see it again in Proposition 8. Proposition 8 would be a terrible mistake for California. It changes our Constitution. Eliminates fundamental rights. And treats people differently under the law.

"Proposition 8 is not about schools or our kids. It's about discrimination and we must always say NO to that.

"No matter how you feel about marriage, vote against discrimination.

"And vote NO on 8."

The ad's placement on statewide television happens to coincide with the 30th anniversary of the murder of San Francisco Mayor George Moscone and City Supervisor Harvey Milk. Feinstein, who was President of the San Francisco Board of Supervisors 30 years ago, immediately became the city's mayor at a time of great unrest and anguish. Re-elected twice, she became the first California woman elected to the United States Senate.

The ad can be viewed at http://www.noonprop8.com.


'/>"/>
SOURCE NO on Prop 8
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NCPA Endorses U.S. Senator Saxby Chambliss for Re-Election
2. NCPA Endorses U.S. Senator Norm Coleman for Re-Election
3. NCPA Endorses U.S. Senator Elizabeth Dole For Re-Election
4. NCPA Endorses U.S. Senator Tom Harkin for Re-Election
5. NCPA Endorses U.S. Senator Richard Durbin for Re-Election
6. NCPA Endorses U.S. Senator Mark Pryor for Re-Election
7. NCPA Endorses U.S. Senator Tim Johnson for Re-Election
8. NCPA Endorses U.S. Senator Max Baucus for Re-Election
9. NCPA Endorses U.S. Senator Pat Roberts for Re-Election
10. NCPA Endorses U.S. Senator Gordon Smith for Re-Election
11. Senators Cochran (R-MS), Boxer (D-CA), Brownback (R-KS) and Vitter (R-LA) Add Their Support to Lung Cancer Mortality Reduction Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... The Woodlands, Texas (PRWEB) , ... August 23, 2017 , ... ... the leading denied claims firms in Texas. Founded by Bill Voss, the firm grew ... over a decade and a half of helping clients get the money they deserve ...
(Date:8/23/2017)... ... August 23, 2017 , ... Earlier this month, the Workgroup ... of health IT to create efficiencies in healthcare information exchange and a trusted advisor ... Summer Forum which featured keynote addresses by Donald W. Rucker, MD, head of ...
(Date:8/23/2017)... , ... August 23, 2017 , ... The Stevie® Awards have announced the winners of ... , the world’s premier business awards competition. , Nominees in the 2017 IBAs were not ... a points system based on the total number of awards won in the IBAs with ...
(Date:8/23/2017)... FL (PRWEB) , ... August 23, 2017 , ... ... for traveling medical professionals, recently launched a new website, http://www.cirrusmedicalstaffing.com . The ... to respond to the needs of healthcare professionals who are traveling on short-term ...
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, the ... to the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. ... 139 percent, marking the twelfth year that the company has been included on ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... WARSAW, Ind. , Aug. 7, 2017 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the third quarter of 2017. ... will be paid on or about October 27, 2017 to ... September 22, 2017.  Future declarations of dividends are subject to ...
(Date:8/7/2017)... 2017  Endo International plc (NASDAQ: ENDP ... virtually all known U.S. mesh product liability claims and ... known remaining U.S. claims at reasonable values. Under the ... fourth quarter of 2017 and continuing through the fourth ... 2017 results, the Company intends to increase its mesh ...
Breaking Medicine Technology: